HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Postpartum cholestasis — Clinical Guidelines

Overview

Postpartum cholestasis, also known as obstetric cholestasis, is a liver condition characterized by elevated serum bile acids during pregnancy, often leading to itching (pruritus) without necessarily causing liver failure. It can affect maternal and fetal outcomes if not managed appropriately 6 8.

Diagnosis

Key Diagnostic Criteria: Elevated serum bile acid levels 6.

Recommended Tests: Serum bile acid measurement is crucial for diagnosis 6.

Grading: No standardized grading system mentioned; management often depends on bile acid levels and maternal/fetal risk 8.

Management

First-Line Treatments: Ursodeoxycholic acid (UDCA) is commonly recommended, typically starting at 10-15 mg/kg/day 8.

Adjunctive Treatments: Supplementation with fat-soluble vitamins, particularly vitamin E, may be necessary to prevent deficiencies 5 7.

Monitoring: Regular monitoring of bile acid levels and maternal/fetal well-being is essential 6 8.

Delivery Considerations: Indicated if bile acid levels remain high, or if there are signs of fetal distress 8.

Special Populations

Pregnancy: Focus on maternal pruritus management and fetal surveillance; UDCA is first-line 6 8.

Pediatrics: Fat-soluble vitamin deficiencies are common; supplementation with absorbable formulations like Tocofersolan is recommended 5 7.

Key Recommendations

Initiate Ursodeoxycholic Acid (UDCA) for elevated bile acid levels to manage symptoms and reduce complications (Evidence: Moderate 8).

Regular monitoring of serum bile acid levels throughout pregnancy to guide management decisions (Evidence: Moderate 6 8).

Consider early delivery if bile acid levels remain persistently elevated or if there are signs of fetal compromise (Evidence: Expert opinion 8).

References

1 Degrassi I, Leonardi I, Di Profio E, Montanari C, Zuccotti G, Verduci E. Fat-Soluble Vitamins Deficiency in Pediatric Cholestasis: A Scoping Review. Nutrients 2023. link 2 Chongthavornvasana S, Lertudomphonwanit C, Mahachoklertwattana P, Korwutthikulrangsri M. Determination of Optimal Vitamin D Dosage in Children with Cholestasis. BMC pediatrics 2023. link 3 Mancell S, Islam M, Dhawan A, Whelan K. Fat-soluble vitamin assessment, deficiency and supplementation in infants with cholestasis. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association 2022. link 4 Kamath BM, Alonso EM, Heubi JE, Karpen SJ, Sundaram SS, Shneider BL et al.. Fat Soluble Vitamin Assessment and Supplementation in Cholestasis. Clinics in liver disease 2022. link 5 Thébaut A, Nemeth A, Le Mouhaër J, Scheenstra R, Baumann U, Koot B et al.. Oral Tocofersolan Corrects or Prevents Vitamin E Deficiency in Children With Chronic Cholestasis. Journal of pediatric gastroenterology and nutrition 2016. link 6 Steele G. Reflection on a pregnancy complicated by obstetric cholestasis. The practising midwife 2012. link 7 Shen YM, Wu JF, Hsu HY, Ni YH, Chang MH, Liu YW et al.. Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis. Journal of pediatric gastroenterology and nutrition 2012. link 8 Saleh MM, Abdo KR. Consensus on the management of obstetric cholestasis: National UK survey. BJOG : an international journal of obstetrics and gynaecology 2007. link 9 Francavilla R, Miniello VL, Brunetti L, Lionetti ME, Armenio L. Hepatitis and cholestasis in infancy: clinical and nutritional aspects. Acta paediatrica (Oslo, Norway : 1992). Supplement 2003. link 10 Le Gars L. Bone involvement in patients with chronic cholestasis. Joint bone spine 2002. link00413-x) 11 Kordzaya DJ, Goderdzishvili VT. Pathogenesis of endotoxemia and multiple organ failure in case of mechanical jaundice and their aggravation after the relief of cholestasis. Przeglad lekarski 2000. link 12 Ishibashi S, Schwarz M, Frykman PK, Herz J, Russell DW. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. The Journal of biological chemistry 1996. link 13 Adinma JI. Acute puerperal coital headache and hypertension. The Australian & New Zealand journal of obstetrics & gynaecology 1994. link 14 Abei M, Nuutinen H, Kawczak P, Schwarzendrube J, Pillay SP, Holzbach RT. Identification of human biliary alpha 1-acid glycoprotein as a cholesterol crystallization promoter. Gastroenterology 1994. link95643-x) 15 Hardikar W, Smith AL, Keith CG, Chow CW. Multisystem obstruction with cholestasis, pigmentary retinopathy, and cleft palate: a new syndrome?. American journal of medical genetics 1992. link 16 Danielsson B, Ekman R, Johansson BG, Petersson BG. Plasma lipoprotein changes in experimental cholestasis in the dog. Clinica chimica acta; international journal of clinical chemistry 1977. link90275-3) 17 Hankiewicz J, Rudzka E. The effect of external drainage of bile on cholesterolemia. Atherosclerosis 1975. link90012-x)

Postpartum cholestasis